Surescripts®, the nation’s leading health intelligence network, introduces its Patient Experience product, Script Corner™, to ...

GoodRx reports Medicaid work requirements for adults in 40 states will begin Jan. 1, 2027, potentially causing 5 million to ...

Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.

Scholar Rock , a global biopharmaceutical company dedicated to dramatically improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating ...

Antitrust activity, which made headlines in 2025 with high profile cases, will continue in 2026 as new laws and leadership ...

Ceres AI, the company behind one of the world's most advanced agricultural intelligence platforms, today announced a renewed and enhanced integration with the John Deere Operations Centertm. While ...

GoodRx's telemedicine service offers oral semaglutide for weight loss, with initial pricing of $149 for 1.5 mg and 4 mg doses ...

GoodRx is downgraded to neutral as declining consumer trends and policy risks outweigh prior valuation appeal. GDRX's active customer base fell 17% y/y in Q3, which the company blamed on Rite Aid ...

Possible implications of TrumpRx, the federal Direct-To-Consumer sales channel, are starting to emerge ahead of its scheduled launch next year. It has been reported that prescription drug savings ...

Looking for ways to slim down and improve your health? You've probably heard about GLP-1s — the buzzworthy prescription medication behind some of today's most talked-about weight loss stories. They've ...

At the 2025 JP Morgan Healthcare Conference, GoodRx’s recently appointed CEO Wendy Barnes highlighted the company’s strategic ...